Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Sotio Biotech Inc.
Sotio Biotech Inc.
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Tesaro, Inc.
Sotio Biotech Inc.
Pfizer
Shasqi, Inc.
Alaunos Therapeutics
Incyte Corporation
Mural Oncology, Inc
Masonic Cancer Center, University of Minnesota
Herlev Hospital
M.D. Anderson Cancer Center
Numab Therapeutics AG
Mayo Clinic
Pfizer
Thomas Jefferson University
NextCure, Inc.
M.D. Anderson Cancer Center
Elevation Oncology
University of Pennsylvania
North Eastern German Society of Gynaecological Oncology
Deciphera Pharmaceuticals, LLC
Deciphera Pharmaceuticals, LLC
Astellas Pharma Inc
Five Prime Therapeutics, Inc.
Pfizer
Opna Bio LLC
AbbVie
Rain Oncology Inc
Bracco Diagnostics, Inc
Bracco Diagnostics, Inc
NantCell, Inc.
University of Pittsburgh
NantCell, Inc.
ModernaTX, Inc.
Pfizer
NextCure, Inc.
ADC Therapeutics S.A.
Sumitomo Pharma America, Inc.
Pfizer
M.D. Anderson Cancer Center
University of Washington
pharmaand GmbH
CytomX Therapeutics
University of Washington
Eastern Cooperative Oncology Group
Sumitomo Pharma America, Inc.
Brown University